![Kelyniam Global Inc. logo](/news-release/logo/222246/0/222246.jpg?lastModified=12%2F09%2F2016%2023%3A32%3A54&size=2)
Kelyniam Global Inc. Announces Second Quarter 2012 Revenues
October 15, 2012 09:29 ET
|
Kelyniam Global Inc.
Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Second Quarter Results
Kelyniam Global Inc. (OTC: KLYG) For the quarter ending June
30th 2012 Kelyniam Global Inc. reported a loss of
$45,692...
U.S Food and Drug Administration Clears PositiveID's iglucose System for Diabetes Management
November 16, 2011 08:30 ET
|
PositiveID Corporation
iglucose is a First-of-its-Kind Wireless Communication System for Diabetes Management
PositiveID to Begin Commercialization Efforts in First Quarter 2012
DELRAY BEACH, Fla., Nov. 16, 2011 (GLOBE...
Michelson Diagnostics VivoSight(TM) OCT Scanner Receives FDA 510(k) Clearance
January 12, 2010 14:00 ET
|
Michelson Diagnostics
ORPINGTON, United Kingdom, Jan. 12, 2010 (GLOBE NEWSWIRE) -- Michelson Diagnostics Ltd, the London, UK based developer and manufacturer of Optical Coherence Tomography (OCT) products, announced today...
Celltech Group plc Submits Xyrem for Approval in Europe
April 01, 2004 01:02 ET
|
Celltech Group plc
SLOUGH, U.K., April 1, 2004 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) today announces that the European Medicines Evaluation Agency (EMEA) has accepted for review its marketing...